Telehealth provider for genetic testing laboratory GRAIL wrongly warns more than 400 patients could have cancer
The incident serves as a reminder that all clinical laboratories can be one mistake away from reporting erroneous results to a number of doctors and patients In May, more than 400 patients who agreed to have the Galleri Early Multi-Cancer Detection (MCED) blood test by GRAIL, a California-based biotechnology company owned by gene technology developer … Read more